“Treatment with medical cannabis oils was safe and well tolerated, and resulted in a reduction in pain intensity, spasticity and sleep disturbances in MS patients.”
Published in the December 2020 issue of Multiple Sclerosis and Related Disorders, the study observed 28 multiple sclerosis patients receive three types of cannabis oil: a THC-rich oil, a CBD-rich oil, and one combining both THC and CBD.
The patients in the study received daily doses of 4mg and 7mg of THC and CBD, respectively, and were primarily administered in the evening.
Over the course of four weeks, the researchers tested the patients according to the Expanded Disability Status Scale (EDSS), and also examined their ambulation, plasma cannabinoid, dexterity, and processing speed, in addition to routine blood tests.
The full article about this and other MS-focused studies from Cannigma.com is here.